Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Macrogenics (NQ: MGNX )

4.680 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.680
Bid (Size) 4.460 (5)
Ask (Size) 5.080 (5)
Prev. Close 4.680
Today's Range 4.680 - 4.680
52wk Range 2.934 - 7.712
Shares Outstanding 61,107,288
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire

Performance

YTD
-26.42%
-26.42%
1 Month
-10.34%
-10.34%
3 Month
-15.68%
-15.68%
6 Month
-32.66%
-32.66%
1 Year
+48.10%
+48.10%

More News

Read More
3 Under-the-Radar Biotech Stocks to Buy in 2023
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Shares of MacroGenics Are Jumping Thursday
Via The Motley Fool
MacroGenics (MGNX) Q1 2023 Earnings Call Transcript
Via The Motley Fool
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss
Via Benzinga
Topics ETFs Economy
Exposures Interest Rates
Recap: Macrogenics Q1 Earnings
Via Benzinga
Earnings Outlook For Macrogenics
Via Benzinga
What 4 Analyst Ratings Have To Say About Macrogenics
Via Benzinga
Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
MacroGenics (MGNX) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
Why MacroGenics Stock Tumbled Today
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Via Benzinga
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
From MacroGenics, Inc.
Via GlobeNewswire
Why MacroGenics Stock Inched Higher on Monday
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
Via Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.